why choose us

First received: June 20, 2023

Clinical Trial: A Study to Evaluate the Safety and Efficacy of NEXAGON® (Lufepirsen Ophthalmic Gel) in Subjects With PCED

Study Status: Completed

Recruit Status: RECRUITING

Condition: Persistent Corneal Epithelial Defect

Study Type: INTERVENTIONAL


Official Title: A Randomized, Multicenter, Double-Masked, Vehicle-Controlled Phase 2/3 Study to Evaluate the Safety and Efficacy of NEXAGON® (Lufepirsen Ophthalmic Gel) in Subjects With Persistent Corneal Epithe

Brief Summary: This study is to evaluate the safety and efficacy of NEXAGON® (lufepirsen ophthalmic gel) (NEXAGON) in subjects with persistent corneal epithelial defects (PCED).The objectives of the study are to evaluate the safety and efficacy of NEXAGON in this population.

Read more